FITC Anti-CD8 alpha antibody [EPR21769]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Recombinant Monoclonal CD8 alpha antibody - conjugated to FITC. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 9 publications.
View Alternative Names
CD8a, Lyt-2, Lyt2, Cd8a, T-cell surface glycoprotein CD8 alpha chain, T-cell surface glycoprotein Lyt-2
- Flow Cyt
Unknown
Flow Cytometry - FITC Anti-CD8 alpha antibody [EPR21769] (AB237367)
C57BL/6 mouse splenocytes stained with ab237367 (right) or Rabbit IgG FITC (monoclonal) (left). C57BL/6 Mouse splenocytes were incubated for 30 mins on ice in 1x PBS containing 10 μg/ml anti CD16/32 antibody and 10% normal goat serum to block FC receptors and non-specific protein-protein interactions followed by the antibody (ab237367) or Rabbit IgG FITC Isotype (1x106 in 100 μl at 1 : 500 (1 μg/ml)) for 30 mins on ice. The cells were simultaneously stained with CD4 PerCP conjugated antibody.
Acquisition of >50,000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter. Events were gated on viable lymphocytes.
Related conjugates and formulations (8)
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD8 alpha antibody [EPR21769]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD8 alpha antibody [EPR21769]
-
660 APC
APC Anti-CD8 alpha antibody [EPR21769]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD8 alpha antibody [EPR21769]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD8 alpha antibody [EPR21769]
-
578 PE
PE Anti-CD8 antibody [EPR21769]
-
Anti-CD8 alpha antibody [EPR21769]
-
Anti-CD8 alpha antibody [EPR21769] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.
Pathways
CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha’s role in adaptive immunity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
The Journal of clinical investigation 135: PubMed40759576
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pharmaceutical analysis 15:101181 PubMed40337128
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology and toxicology 41:82 PubMed40335763
2025
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 27:31 PubMed40045365
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23842 PubMed39588744
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 14:e1800 PubMed39305055
2024
Applications
Unspecified application
Species
Unspecified reactive species
Immunotherapy 16:975-985 PubMed39115961
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:69 PubMed38238314
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:5218-5235 PubMed38058799
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com